Cytopenia and autoimmune diseases: a vicious cycle fueled by mTOR dysregulation in hematopoietic stem cells.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Journal of Autoimmunity

• Publication date

  2013-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.jaut.2012.12.011PMID 23375848PMCID PMC3622805
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Autoimmune diseases in the intensive care unit. An update.

  2013cited by this paper
• Everolimus for Subependymal Giant-Cell Astrocytomas in Tuberous Sclerosis

  2012cited by this paper
• Rapamycin/IL-2 Combination Therapy in Patients With Type 1 Diabetes Augments Tregs yet Transiently Impairs β-Cell Function

  2012cited by this paper
• How I treat acquired aplastic anemia.

  2012cited by this paper
• Epigenetics, autoimmunity and hematologic malignancies: a comprehensive review.

  2012cited by this paper
• Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-Linked Syndrome: A Paradigm of Immunodeficiency with Autoimmunity

  2012cited by this paper
• Heritability versus the role of the environment in autoimmunity.

  2012cited by this paper
• Mechanisms of environmental influence on human autoimmunity: a National Institute of Environmental Health Sciences expert panel workshop.

  2012cited by this paper
• An emerging role for TOR signaling in mammalian tissue and stem cell physiology

  2011cited by this paper
• Autoimmunity in common variable immunodeficiency: correlation with lymphocyte phenotype in the French DEFI study.

  2011cited by this paper
• Beta cell function during rapamycin monotherapy in long-term type 1 diabetes

  2011cited by this paper
• Mammalian Target of Rapamycin (mTOR) Inhibitors

  2011cited by this paper
• Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis.

  2010cited by this paper
• Mammalian target of rapamycin activation underlies HSC defects in autoimmune disease and inflammation in mice.

  2010cited by this paper
• Clinical and immunological overlap between autoimmune lymphoproliferative syndrome and common variable immunodeficiency.

  2010cited by this paper
• The physiopathology of the catastrophic antiphospholipid (Asherson's) syndrome: compelling evidence.

  2009cited by this paper
• The evolutionary conundrum of pathogen mimicry

  2009cited by this paper
• Posttransplant anemia: the role of sirolimus.

  2009cited by this paper
• Homeostatic Proliferation in the Mice with Germline FoxP3 Mutation and its Contribution to Fatal Autoimmunity1

  2008cited by this paper
• Common variable immune deficiency (CVID) presenting as an autoimmune disease: role of memory B cells.

  2008cited by this paper
• Safety issues in the management of autoimmune hepatitis.

  2008cited by this paper
• Guillain-Barré syndrome

  2008cited by this paper
• TSC–mTOR maintains quiescence and function of hematopoietic stem cells by repressing mitochondrial biogenesis and reactive oxygen species

  2008cited by this paper
• Use of Sirolimus in IPEX and IPEX-Like Children

  2008cited by this paper
• Clinical and molecular profile of a new series of patients with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome: inconsistent correlation between forkhead box protein 3 expression and disease severity.

  2008cited by this paper
• The TSC1-TSC2 Complex Is Required for Proper Activation of mTOR Complex 2

  2008influential reference
• Higher maximal serum concentration of methotrexate predicts the incidence of adverse reactions in Japanese rheumatoid arthritis patients

  2007cited by this paper
• FoxOs are critical mediators of hematopoietic stem cell resistance to physiologic oxidative stress.

  2007cited by this paper
• Expanding mTOR signaling

  2007cited by this paper
• Multistep pathogenesis of autoimmune disease.

  2007cited by this paper
• PTEN maintains haematopoietic stem cells and acts in lineage choice and leukaemia prevention

  2006cited by this paper
• TSC1/TSC2 and Rheb have different effects on TORC1 and TORC2 activity.

  2006influential reference
• Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells

  2006cited by this paper
• Identification of Sin1 as an essential TORC2 component required for complex formation and kinase activity.

  2006cited by this paper
• TSC2 integrates Wnt and energy signals via a coordinated phosphorylation by AMPK and GSK3 to regulate cell growth.

  2006cited by this paper
• Rapamycin reduces disease activity and normalizes T cell activation-induced calcium fluxing in patients with systemic lupus erythematosus.

  2006cited by this paper
• Treatment and outcome of autoimmune hematologic disease in common variable immunodeficiency (CVID).

  2005cited by this paper
• [Guillain-Barré syndrome].

  2005cited by this paper
• The Scurfy mutation of FoxP3 in the thymus stroma leads to defective thymopoiesis

  2005cited by this paper
• Successful use of the new immune-suppressor sirolimus in IPEX (immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome).

  2005cited by this paper
• CD24 Expression on T Cells Is Required for Optimal T Cell Proliferation in Lymphopenic Host

  2004cited by this paper
• Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses.

  2004cited by this paper
• Guillain-Barré syndrome

  2004cited by this paper
• Homeostatic expansion of T cells during immune insufficiency generates autoimmunity.

  2004cited by this paper
• Ex Vivo Homeostatic Proliferation of CD4+ T Cells in Rheumatoid Arthritis Is Dysregulated and Driven by Membrane-Anchored TNFα1

  2004cited by this paper
• The human DiGeorge syndrome critical region gene 8 and Its D. melanogaster homolog are required for miRNA biogenesis.

  2004cited by this paper
• Dysregulation of the TSC-mTOR pathway in human disease

  2004cited by this paper
• Review of ACR hematologic criteria in systemic lupus erythematosus

  2004cited by this paper
• Autoimmune enteropathy: molecular concepts

  2004cited by this paper
• Management of infections in the neutropenic patient.

  2004cited by this paper
• Immune dysregulation, polyendocrinopathy, enteropathy, and X-linked inheritance (IPEX), a syndrome of systemic autoimmunity caused by mutations of FOXP3, a critical regulator of T-cell homeostasis

  2003cited by this paper
• Supporting Online Material

  2003cited by this paper
• Thymic Export Function and T Cell Homeostasis in Patients with Relapsing Remitting Multiple Sclerosis1

  2003cited by this paper
• Evans Syndrome in a Patient with Chromosome 22q11.2 Deletion Syndrome: A Case Report

  2003cited by this paper
• TSC2 mediates cellular energy response to control cell growth and survival.

  2003cited by this paper
• Neonates support lymphopenia-induced proliferation.

  2003cited by this paper
• Aire regulates negative selection of organ-specific T cells

  2003cited by this paper
• The tuberous sclerosis complex (TSC) pathway and mechanism of size control.

  2003cited by this paper
• Lymphopenia in the BB rat model of type 1 diabetes is due to a mutation in a novel immune-associated nucleotide (Ian)-related gene.

  2002cited by this paper
• The diabetes-prone BB rat carries a frameshift mutation in Ian4, a positional candidate of Iddm1.

  2002cited by this paper
• Akt regulates growth by directly phosphorylating Tsc2

  2002cited by this paper
• TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling

  2002cited by this paper
• Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome

  2002cited by this paper
• Innate immune recognition.

  2002cited by this paper
• Chronic arthritis associated with chromosome deletion 22q11.2 syndrome.

  2002cited by this paper
• The Role of αβ+ T Cells and Homeostatic T Cell Proliferation in Y-Chromosome-Associated Murine Lupus1

  2001cited by this paper
• Drosophila Tsc1 functions with Tsc2 to antagonize insulin signaling in regulating cell growth, cell proliferation, and organ size.

  2001cited by this paper
• Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse

  2001cited by this paper
• X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy

  2001cited by this paper
• TSC1 and TSC2 tumor suppressors antagonize insulin signaling in cell growth.

  2001cited by this paper
• Thymic function and peripheral T-cell homeostasis in rheumatoid arthritis.

  2001cited by this paper
• Juvenile idiopathic polyarticular arthritis and IgA deficiency in the 22q11 deletion syndrome.

  2001cited by this paper
• Treatment of the immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) by allogeneic bone marrow transplantation.

  2001cited by this paper
• The role of alpha beta+ T cells and homeostatic T cell proliferation in Y-chromosome-associated murine lupus.

  2001cited by this paper
• The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3

  2001cited by this paper
• Cytopenia and past human parvovirus B19 infection in patients with primary Sjögren's syndrome.

  2000cited by this paper
• JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome.

  2000cited by this paper
• Homeostatic T Cell Proliferation

  2000cited by this paper
• Homeostasis-Stimulated Proliferation Drives Naive T Cells to Differentiate Directly into Memory T Cells

  2000cited by this paper
• Naive T Cells Transiently Acquire a Memory-like Phenotype during Homeostasis-Driven Proliferation

  2000cited by this paper
• DiGeorge syndrome with Graves' disease: A case report.

  2000cited by this paper
• Sirolimus-induced thrombocytopenia and leukopenia in renal transplant recipients: risk factors, incidence, progression, and management.

  2000cited by this paper
• The peptide ligands mediating positive selection in the thymus control T cell survival and homeostatic proliferation in the periphery.

  1999cited by this paper
• Low-affinity ligands for the TCR drive proliferation of mature CD8+ T cells in lymphopenic hosts.

  1999cited by this paper
• Juvenile rheumatoid arthritis-like polyarthritis in chromosome 22q11.2 deletion syndrome (DiGeorge anomalad/velocardiofacial syndrome/conotruncal anomaly face syndrome).

  1997cited by this paper
• Cytotoxic therapy in systemic lupus erythematosus. Experience from a single center.

  1997cited by this paper
• CD4 cytopenia and occasional expansion of CD4+CD8+lymphocytes in Sjögren's syndrome.

  1996cited by this paper
• Pancytopenia and severe cytopenia induced by low-dose methotrexate. Eight case-reports and a review of one hundred cases from the literature (with twenty-four deaths)

  1995cited by this paper
• Transplantation of T cell-mediated, lymphoreticular disease from the scurfy (sf) mouse.

  1994cited by this paper
• Fatal lymphoreticular disease in the scurfy (sf) mouse requires T cells that mature in a sf thymic environment: potential model for thymic education.

  1991cited by this paper
• The scurfy mouse mutant has previously unrecognized hematological abnormalities and resembles Wiskott-Aldrich syndrome.

  1990cited by this paper
• Neonatal thymectomy results in a repertoire enriched in T cells deleted in adult thymus.

  1989cited by this paper
• Toxicity of methotrexate in rheumatoid arthritis.

  1987cited by this paper
• IKKb Suppression of TSC1 Links Inflammation and Tumor Angiogenesis via the mTOR Pathway

  year unknowncited by this paper

• Early Outcome of Aflibercept 8 mg for Neovascular AMD in the Real-world Setting

  2025cites this paper
• Comprehensive immunological blood analysis of children of different age groups on the background of allergic reactions

  2025cites this paper
• Metabolic regulation of Th17 and Treg cell balance by the mTOR signaling

  2025cites this paper
• Unraveling the pathogenesis of myelosuppression and therapeutic potential of natural products.

  2024cites this paper
• Hematopoietic Stem Cell: Regulation and Nutritional Intervention

  2023cites this paper
• Association between radioactive iodine uptake and neutropenia in untreated Graves’ disease

  2023cites this paper
• Aggf1 Specifies Hemangioblasts at the Top of Regulatory Hierarchy via Npas4l and mTOR-S6K-Emp2-ERK Signaling

  2023cites this paper
• The impact of pre‐transplant anti‐HLA antibodies in transplants from HLA‐identical sibling donors: A multicenter study

  2023cites this paper
• Rituximab resistance in ITP and beyond

  2023cites this paper
• Stem Cell Therapy in Lupus

  2022cites this paper
• Impact of total splenectomy on peripheral lymphocytes and their subsets in patients with hypersplenism associated with cirrhotic portal hypertension

  2021cites this paper
• Impact of Total Splenectomy on Peripheral Lymphocytes and Their Subsets in Patients with Hypersplenism Associated with Cirrhotic Portal Hypertension

  2021cites this paper
• mTOR Signaling as a Regulator of Hematopoietic Stem Cell Fate

  2021cites this paper
• Lymphopenia and lymphocytosis in practical healthy people born and living in the North

  2020cites this paper
• Excellent response of severe aplastic anemia to treatment of gut inflammation: A case report and review of the literature

  2020cites this paper
• Elucidation of the molecular mechanism of Sanguisorba Officinalis L. against leukopenia based on network pharmacology.

  2020cites this paper
• PKN1 kinase-negative knock-in mice develop splenomegaly and leukopenia at advanced age without obvious autoimmune-like phenotypes

  2019cites this paper
• Autoimmune disease in patients with diffuse large B-cell lymphoma: occurrence and impact on outcome

  2019cites this paper
• Human liver stem cells attenuate concanavalin A-induced acute liver injury by modulating myeloid-derived suppressor cells and CD4+ T cells in mice

  2019cites this paper
• Ataluren‐driven restoration of Shwachman‐Bodian‐Diamond syndrome protein function in Shwachman‐Diamond syndrome bone marrow cells

  2018cites this paper
• Berberine inhibits IL‐21/IL‐21R mediated inflammatory proliferation of fibroblast‐like synoviocytes through the attenuation of PI3K/Akt signaling pathway and ameliorates IL‐21 mediated osteoclastogenesis

  2018cites this paper
• Rapamycin is highly effective in murine models of immune-mediated bone marrow failure

  2017cites this paper
• Sirolimus as an Effective Agent in the Treatment of Immune Thrombocytopenia (ITP) and Evans Syndrome (ES): A Single Institution’s Experience

  2017cites this paper
• Neutropenia in Patients with Common Variable Immunodeficiency: a Rare Event Associated with Severe Outcome

  2017cites this paper
• Causes of peripheral cytopenia in hepatitic cirrhosis and portal hypertensive splenomegaly

  2017cites this paper
• Arteriosclerosis, Thrombosis, and Vascular Biology.

  2016cites this paper
• Sirolimus for Refractory Autoimmune Hemolytic Anemia after Allogeneic Hematopoietic Stem Cell Transplantation: A Case Report and Literature Review of the Treatment of Post-Transplant Autoimmune Hemolytic Anemia.

  2016cites this paper
• Non-Hypersplenism Causes of Peripheral Cytopenias in Patients with Cirrhotic Portal Hypertension: A Review

  2016cites this paper
• Type I IFNs Act upon Hematopoietic Progenitors To Protect and Maintain Hematopoiesis during Pneumocystis Lung Infection in Mice

  2015cites this paper
• This information is current as Infection in Mice Lung Pneumocystis Hematopoiesis during Progenitors To Protect and Maintain Type I IFNs Act upon Hematopoietic

  2015cites this paper
• Autoimmunity in 2013

  2014cites this paper
• Lung Infection Pneumocystis during Systemic Responses to IFNs Protects Bone Marrow Homeostasis Pulmonary Immune Activation by Type I Modulation of Inflammasome-Mediated

  2013cites this paper
• Modulation of Inflammasome-Mediated Pulmonary Immune Activation by Type I IFNs Protects Bone Marrow Homeostasis during Systemic Responses to Pneumocystis Lung Infection

  2013cites this paper
• Regulation of Interferon Gamma Signaling by Suppressors of Cytokine Signaling and Regulatory T Cells

  2013cites this paper